• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吲哚胺2,3-双加氧酶在小鼠体内的神经元定位

Neuronal localization of indoleamine 2,3-dioxygenase in mice.

作者信息

Roy Edward J, Takikawa Osamu, Kranz David M, Brown Alicia R, Thomas Diana L

机构信息

Neuroscience Program and Department of Pathology, College of Medicine, University of Illinois at Urbana-Champaign, 506 S. Mathews Avenue, Urbana, IL 61801, USA.

出版信息

Neurosci Lett. 2005 Oct 21;387(2):95-9. doi: 10.1016/j.neulet.2005.07.010.

DOI:10.1016/j.neulet.2005.07.010
PMID:16076525
Abstract

Indoleamine 2,3-dioxygenase (IDO) catabolizes tryptophan to kynurenine. In the immune system, the reduction in tryptophan and increase in kynurenine act to suppress T-cell function. In the nervous system, kynurenine can be further metabolized to quinolinic acid, which can be neurotoxic. IDO is known to be expressed by microglia and its levels are upregulated by interferon-gamma (IFNgamma). We report here that IDO immunoreactivity is also localized in neurons, and that IDO is upregulated by IFNgamma in neurons of the hippocampus. Thus, neuronal IDO could contribute to the vulnerability of neurons to inflammatory conditions.

摘要

吲哚胺2,3-双加氧酶(IDO)将色氨酸分解代谢为犬尿氨酸。在免疫系统中,色氨酸的减少和犬尿氨酸的增加会抑制T细胞功能。在神经系统中,犬尿氨酸可进一步代谢为喹啉酸,后者具有神经毒性。已知小胶质细胞可表达IDO,且其水平会被γ干扰素(IFNγ)上调。我们在此报告,IDO免疫反应性也定位于神经元,并且在海马体神经元中,IDO会被IFNγ上调。因此,神经元IDO可能导致神经元在炎症状态下更易受损。

相似文献

1
Neuronal localization of indoleamine 2,3-dioxygenase in mice.吲哚胺2,3-双加氧酶在小鼠体内的神经元定位
Neurosci Lett. 2005 Oct 21;387(2):95-9. doi: 10.1016/j.neulet.2005.07.010.
2
Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.人小胶质细胞、星形胶质细胞和神经元中吲哚胺2,3-双加氧酶的表达及喹啉酸的产生。
Glia. 2005 Jan 1;49(1):15-23. doi: 10.1002/glia.20090.
3
Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus.阿尔茨海默病海马体中吲哚胺2,3-双加氧酶和喹啉酸免疫反应性
Neuropathol Appl Neurobiol. 2005 Aug;31(4):395-404. doi: 10.1111/j.1365-2990.2005.00655.x.
4
The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.色氨酸沿吲哚胺2,3-双加氧酶(IDO)途径的分解代谢产物(TRYCATs)的免疫效应:与抑郁症及其他以炎症诱导的色氨酸耗竭为特征的病症的相关性。
Neuro Endocrinol Lett. 2007 Dec;28(6):826-31.
5
Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).干扰素γ诱导的胶原凝胶中驻留的成纤维细胞(FPCG)的吲哚胺2,3-双加氧酶表达可抑制免疫细胞增殖。
J Cell Biochem. 2003 Sep 1;90(1):206-17. doi: 10.1002/jcb.10593.
6
Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.实验性脑型和非脑型疟疾中沿犬尿氨酸途径的氧化色氨酸代谢的显著变化。
Am J Pathol. 1998 Feb;152(2):611-9.
7
Combined inhibition of indoleamine 2,3-dioxygenase and nitric oxide synthase modulates neurotoxin release by interferon-gamma-activated macrophages.吲哚胺2,3-双加氧酶和一氧化氮合酶的联合抑制可调节干扰素-γ激活的巨噬细胞释放神经毒素。
J Leukoc Biol. 2000 Aug;68(2):260-6.
8
Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.表达转导吲哚胺2,3-双加氧酶的树突状细胞对同种异体T细胞反应的抑制作用。
J Gene Med. 2005 May;7(5):565-75. doi: 10.1002/jgm.698.
9
Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.干扰素-γ、吲哚胺2,3-双加氧酶与色氨酸分解代谢之间的关系。
FASEB J. 1991 Aug;5(11):2516-22.
10
A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.炎症性神经疾病中脑内喹啉酸形成的机制。6-氯色氨酸和4-氯-3-羟基邻氨基苯甲酸对L-色氨酸合成的抑制作用。
Brain. 1993 Dec;116 ( Pt 6):1425-50. doi: 10.1093/brain/116.6.1425.

引用本文的文献

1
Indoleamine 2, 3-dioxygenase is responsible for low stress tolerance after intracerebral hemorrhage.色氨酸 2,3-双加氧酶负责脑出血后低应激耐受性。
PLoS One. 2023 Feb 8;18(2):e0273037. doi: 10.1371/journal.pone.0273037. eCollection 2023.
2
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?脑恶性肿瘤的免疫治疗:与其他部位有何不同?
Front Oncol. 2016 Dec 7;6:256. doi: 10.3389/fonc.2016.00256. eCollection 2016.
3
Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain.
色氨酸 2,3-双加氧酶的表达及犬尿氨酸途径代谢产物在三转基因小鼠和人类阿尔茨海默病脑中的产生。
PLoS One. 2013 Apr 22;8(4):e59749. doi: 10.1371/journal.pone.0059749. Print 2013.
4
Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression.脑色氨酸 2,3-双加氧酶导致疼痛和抑郁共病。
J Clin Invest. 2012 Aug;122(8):2940-54. doi: 10.1172/JCI61884. Epub 2012 Jul 2.
5
Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice.小鼠脑缺血再灌注后吲哚胺 2,3-双加氧酶-1 的血管表达、活性和功能。
Naunyn Schmiedebergs Arch Pharmacol. 2011 May;383(5):471-81. doi: 10.1007/s00210-011-0611-4. Epub 2011 Feb 27.
6
Circulating Antibodies to IDO/THO Pathway Metabolites in Alzheimer's Disease.阿尔茨海默病中针对吲哚胺2,3-双加氧酶/THO途径代谢物的循环抗体
Int J Alzheimers Dis. 2010 Mar 15;2010:501541. doi: 10.4061/2010/501541.
7
Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures.脂多糖的中枢给药会在体内诱导出抑郁样行为,并激活鼠器官型海马切片培养物中的脑色氨酸 2,3 双加氧酶。
J Neuroinflammation. 2010 Aug 2;7:43. doi: 10.1186/1742-2094-7-43.
8
Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions.色氨酸 2,3-双加氧酶在小鼠中的组织分布和细胞定位:对其生物学功能的影响。
J Histochem Cytochem. 2010 Jan;58(1):17-28. doi: 10.1369/jhc.2009.953604. Epub 2009 Sep 9.
9
Characterization of the kynurenine pathway in human neurons.人类神经元中犬尿氨酸途径的特征
J Neurosci. 2007 Nov 21;27(47):12884-92. doi: 10.1523/JNEUROSCI.4101-07.2007.